Reuters logo
BRIEF-AzurRx provides update on MS1819 phase II trial
April 11, 2017 / 12:16 PM / 6 months ago

BRIEF-AzurRx provides update on MS1819 phase II trial

April 11 (Reuters) - AzurRx Biopharma Inc

* AzurRx provides update on MS1819 phase II trial

* AzurRx Biopharma Inc - Early results indicate that MS1819 exhibits a favorable safety profile Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below